Drugmaker will collaborate with Web startup to develop personalized healthcare plans
A recently launched website for consumer health, Keas (San Francisco), seeks to combine electronic health records (EHRs) with health guidance and recommendations based in part on what those records indicate. While not a version of online medical care (not yet, anyway), the company’s president, Adam Bosworth, emphasizes that he wants his company to go beyond a mere repository of EHR data. A number of individual physicians and health plans, such as CVS MinuteClinic and Healthwise, an online publishing company that has also supplied care plans to WebMD and others, have already signed on, as has Quest Diagnostics, one of the US’s leading clinical labs.
According to Bosworth, when all the pieces of Keas are in place, doctors, dieticians and others will develop “Care Plans” in much the way that Apple Computer attracts application developers to the iPhone, where they can earn income the more often their apps are downloaded. Individual consumers will upload their EHR data (or link to it from Google Health, Microsoft HealthVault or other repositories), select a care plan, and then interact with the system to help themselves manage their health.
“The desire of consumers to manage their health is well-recognized,” says Bosworth. “This setup will help to make that management more personalized and more powerful by combining EHR data with guidance. Over time, he says, the outcomes of individuals health could lead to a ranking or evaluation of plans, with the better plans succeeding in the end. “As has been said, the US healthcare system is really a sick care system; this is about wellness and ongoing health management.”
Pharma companies like Pfizer will be able to offer care plans along with anyone else, although they will have to meet both advisory-board reviews within Keas and FDA regulations on how drugs are promoted. “We’re still figuring the pharma part out, but we believe that there will be valuable overlaps in things like patient reminders, access to coupons and the like,” says Bosworth. “The Pfizer relationship with Keas enables us to partner with healthcare professionals to extend care management outside the office,” says Olivier Brandicourt, president of Pfizer’s Primary Care Business Unit.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.